سعر روتابلانين 200 مجم فيال للحقن عضل/وريد 2024

Teicoplanin 200 mg vial for intravenous or intramuscular injection, 1 vial, by Rameda > Egypharm; glycopeptide antibiotic.

• Complicated skin and soft tissue infections; bone and joint infections; hospital- and community-acquired pneumonia; complicated urinary tract infections; infective endocarditis; CAPD-associated peritonitis; bacteraemia associated with these indications (adults and children from birth).Population: Adults and children from birthelectronic medicines compendium (emc), UK

• Reported adverse reactions include rash, erythema, pruritus, pain at the injection site, fever, dizziness, headache, leucopenia, thrombocytopenia, eosinophilia, raised transaminases and serum creatinine, and rarely anaphylaxis, DRESS and hearing loss.General active-ingredient information · electronic medicines compendium (emc), UK

• Hypersensitivity to teicoplanin or to any of the excipients.General active-ingredient information · electronic medicines compendium (emc), UK

• Serious, sometimes fatal hypersensitivity reactions (e.g. anaphylactic shock) have been reported; use with caution in patients with known vancomycin hypersensitivity (cross-reactions possible). Not for intraventricular use.General active-ingredient information · electronic medicines compendium (emc), UK
• Infusion-related reactions (red man syndrome) may occur, even at the first dose; infusing the daily dose over 30 minutes rather than as a bolus can limit them.General active-ingredient information · electronic medicines compendium (emc), UK
• Nephrotoxicity and ototoxicity (deafness, tinnitus) have been reported; monitor renal and auditory function, especially with renal impairment, high loading doses, prolonged treatment or other nephrotoxic/ototoxic drugs.General active-ingredient information · electronic medicines compendium (emc), UK

• AminoglycosidesTeicoplanin and aminoglycoside solutions are incompatible and must not be mixed for injection.electronic medicines compendium (emc), UK
• Nephrotoxic / ototoxic drugs (aminoglycosides, colistin, amphotericin B, ciclosporin, cisplatin, furosemide, ethacrynic acid)Use with care concomitantly or sequentially; no evidence of synergistic toxicity but monitoring is advised.electronic medicines compendium (emc), UK

• Limited human data; animal studies showed reproductive toxicity at high doses. Should not be used during pregnancy unless clearly necessary; a potential risk of inner ear and renal damage to the foetus cannot be excluded.General active-ingredient information · electronic medicines compendium (emc), UK
• It is unknown whether teicoplanin is excreted in human milk; decide on breastfeeding versus therapy based on benefit to child and mother.General active-ingredient information · electronic medicines compendium (emc), UK

• Teicoplanin: Inhibits cell-wall biosynthesis by binding D-alanyl-D-alanine residues, blocking peptidoglycan synthesis (UK SmPC).